Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also offers Tablo Data Ecosystem, including TabloHub, a consumer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California. Show more
3052 Orchard Drive, San Jose, CA, 95134, United States
Market Cap
71.55M
52 Wk Range
$3.00 - $21.98
Previous Close
$3.86
Open
$3.85
Volume
249,859
Day Range
$3.84 - $4.41
Enterprise Value
16.46M
Cash
156.7M
Avg Qtr Burn
-12.84M
Insider Ownership
3.62%
Institutional Own.
80.81%
Qtr Updated
03/31/26
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|
